GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guangdong VTR Bio-Tech Co Ltd (SZSE:300381) » Definitions » Total Equity

Guangdong VTR Bio-Tech Co (SZSE:300381) Total Equity : ¥2,672.8 Mil (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Guangdong VTR Bio-Tech Co Total Equity?

Guangdong VTR Bio-Tech Co's total equity for the quarter that ended in Mar. 2024 was ¥2,672.8 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Guangdong VTR Bio-Tech Co Total Equity Historical Data

The historical data trend for Guangdong VTR Bio-Tech Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong VTR Bio-Tech Co Total Equity Chart

Guangdong VTR Bio-Tech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,728.76 3,262.92 3,048.01 2,815.88 2,735.15

Guangdong VTR Bio-Tech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,798.66 2,792.55 2,749.02 2,735.15 2,672.75

Guangdong VTR Bio-Tech Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Guangdong VTR Bio-Tech Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=3094.935-359.786
=2,735.1

Guangdong VTR Bio-Tech Co's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=2953.504-280.754
=2,672.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guangdong VTR Bio-Tech Co Total Equity Related Terms

Thank you for viewing the detailed overview of Guangdong VTR Bio-Tech Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangdong VTR Bio-Tech Co (SZSE:300381) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Pingbei 1st Road, Nanping Science and Technology Industrial Park, Guangdong Province, Zhuhai, CHN, 519060
Guangdong VTR Bio-Tech Co Ltd is a China based biotechnology company. It is engaged in the research, development, production, sales and service of biopharmaceuticals, bio-enzyme preparations, microbial preparations, functional additives and green biological manufacturing engineering. The company's products include Wittler tributyrin, temperature glucose oxidase, Mildew, VTR-TH26 glucoamylase, Sorghum specific compound enzyme, and others. It sells its products in China, and also exports it to various other countries.
Executives
Feng Guo Hua Executives
Du Hong Fang Executives
Chen Shao Mei Directors, executives
Zhou De Rong Directors, Directors, and Executives
Li Hong Bing Director
Ding Si Liang Executives
Liu Dong Xue Director
Qin Qiang Director
Dai Qing Ying Supervisors

Guangdong VTR Bio-Tech Co (SZSE:300381) Headlines

No Headlines